HOME > Articles >

Korean J Gastroenterol  <  Volume 73(6); 2019 <  Articles

Korean J Gastroenterol 2019; 73(6): 373-374  https://doi.org/10.4166/kjg.2019.73.6.373
Genetic Mutation as a Predictive Biomarker for FOLFIRINOX in Patients with Metastatic Pancreatic Adenocarcinoma
Jaihwan Kim
Division of Gastroenterology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
Correspondence to: Jaihwan Kim, Division of Gastroenterology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea. Tel: +82-31-787-7075, Fax: +82-31-787-4050, E-mail: drjaihwan@snu.ac.kr, ORCID: https://orcid.org/0000-0003-0693-1415
Published online: June 25, 2019.
© The Korean Journal of Gastroenterology. All rights reserved.

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


This Article


Author ORCID Information

Stats or Metrics
  • View: 37
  • Download: 30

Services
Social Network Service

e-submission

Archives

Official Journal of

Indexed/Covered by

  • thomson reuters
  • pubmedcentral
  • koreamed
  • crossref
  • crossref
  • synepse
  • kofst
  • DOAJ
  • ORCID